<p>Cross Country Healthcare（纳斯达克：CCRN - 获取免费报告）在周一发布的报告中，Truist Financial 将其目标股价从 10.00 美元上调至 13.25 美元，Benzinga 报道。该券商目前对该商业服务提供商的股票维持 “持有” 评级。Truist Financial 的目标股价表明，相较于股票的前收盘价，存在 0.88% 的潜在上涨空间。</p>
<ul>
<li>在降息前值得购买的前两只小型医疗股</li>
</ul>
<p>其他一些股票研究分析师也对 CCRN 发表了看法。Weiss Ratings 在 3 月 27 日的研究报告中重新发布了 Cross Country Healthcare 的 “卖出（e+）” 评级。花旗集团在周四的研究报告中将 Cross Country Healthcare 的评级从 “市场跑赢” 下调至 “市场表现”。Zacks Research 在 1 月 19 日的研究报告中将 Cross Country Healthcare 的评级从 “强烈卖出” 上调至 “持有”。Wedbush 在周四的研究报告中将 Cross Country Healthcare 的评级从 “跑赢大盘” 下调至 “持有”，并将该公司的目标股价从 15.00 美元下调至 13.25 美元。最后，Citizens Jmp 在周四的研究报告中将 Cross Country Healthcare 的评级从 “强烈买入” 下调至 “持有”。九位分析师对该股票给予了 “持有” 评级，一位分析师给予了 “卖出” 评级。根据 MarketBeat.com 的数据，Cross Country Healthcare 目前的平均评级为 “减持”，共识目标股价为 12.72 美元。</p>
<p><strong>阅读我们关于 CCRN 的最新研究报告</strong></p>
<h2>Cross Country Healthcare 股票下跌 0.3%</h2>
<ul>
<li>这只小型医疗股表现优于其指数</li>
</ul>
<p>周一中午交易时，纳斯达克 CCRN 的股票下跌 0.05 美元，报 13.14 美元。该公司的交易量为 181,468 股，而其平均交易量为 569,250 股。Cross Country Healthcare 的年内最低价为 7.43 美元，年内最高价为 14.99 美元。该公司的 50 日移动平均价格为 9.69 美元，200 日移动平均价格为 9.66 美元。该股票的市值为 4.2295 亿美元，市盈率为-4.31，市盈增长比率为 13.87，贝塔值为 0.35。</p>
<p>Cross Country Healthcare（纳斯达克：CCRN - 获取免费报告）最后一次发布财报是在 5 月 7 日，作为商业服务提供商，该公司报告季度每股收益为（0.03 美元），超出分析师共识预期的（0.05 美元）0.02 美元。Cross Country Healthcare 的股本回报率为-0.74%，净利润率为-9.84%。该公司在本季度的收入为 2.4106 亿美元，而分析师预期为 2.3707 亿美元。整体来看，股票研究分析师预计 Cross Country Healthcare 在当前年度将发布 0.09 美元的每股收益。</p>
<h2>Cross Country Healthcare 的机构交易</h2>
<p>对冲基金和其他机构投资者最近对该股票的持仓进行了调整。BNP Paribas Financial Markets 在第二季度将其在 Cross Country Healthcare 的股份增加了 50.0%。BNP Paribas Financial Markets 目前拥有 3424 股该商业服务提供商的股票，价值 45,000 美元，此前在上个季度又购买了 1142 股。凯通国际资产管理有限公司在第四季度购买了 Cross Country Healthcare 的新股份，价值约 46,000 美元。Tower Research Capital LLC TRC 在第二季度将其在 Cross Country Healthcare 的股份增加了 422.0%。Tower Research Capital LLC TRC 目前拥有 3586 股该商业服务提供商的股票，价值 47,000 美元，此前在上个季度又购买了 2899 股。Graham Capital Management L.P.在第四季度购买了 Cross Country Healthcare 的新股份，价值约 83,000 美元。最后，AXQ Capital LP 在第四季度购买了 Cross Country Healthcare 的新股份，价值约 109,000 美元。对冲基金和其他机构投资者持有该公司 96.03% 的股票。</p>
<h2>关于 Cross Country Healthcare</h2>
<p>（获取免费报告）</p>
<p>Cross Country Healthcare, Inc.总部位于佛罗里达州博卡拉顿，是美国领先的医疗劳动力解决方案提供商。该公司专注于护理和相关健康专业人员的招聘、安置和管理，提供旅行和永久性岗位。通过其综合平台，Cross Country Healthcare 为医院、健康系统和长期护理设施提供服务，将合格的临床人才与不同护理环境中的患者护理需求相匹配。</p>
<p>该公司的核心服务包括旅行护士和相关健康人员的招聘、临时人员招聘、永久安置服务和管理服务项目。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过 Cross Country Healthcare</li>
<li>Meta Platforms 的财报后剧烈波动：分析师目标股价现状</li>
<li>3 只在商品超级周期中表现突出的金属和矿业股票</li>
<li>捕捉下跌的刀子：现在是购买这些被打压股票的时候吗？</li>
<li>星星正在为苹果对齐：准备迎接 300 美元</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUQI2U3ltYm9sPUNDUk4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUQI2U3ltYm9sPUNDUk4"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Cross Country Healthcare 吗？</h2>
<p>在考虑 Cross Country Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Cross Country Healthcare 并不在名单上。</p>
<p>虽然 Cross Country Healthcare 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

Cross Country医疗保健

标普医疗保健服务 ETF - SPDR

美国医疗保健供应商 ETF - iShares

医疗业 ETF - Vanguard

医疗业 ETF - SPDR

标普全球医疗股指数 ETF - iShares

<p>Truist Financial 已将 Cross Country Healthcare（NASDAQ:CCRN）的目标价从 10.00 美元上调至 13.25 美元，维持 “持有” 评级。这个新目标暗示该股票相较于前一交易日收盘价有 0.88% 的潜在上涨空间。其他分析师的意见各异，Weiss Ratings 给出了 “卖出” 评级，而花旗集团则下调至 “市场表现”。目前，CCRN 的交易价格为 13.14 美元，市值为 4.2295 亿美元，市场共识目标价为 12.72 美元</p>

<p>Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) had its price target hoisted by research analysts at Truist Financial from $10.00 to $13.25 in a report released on Monday,Benzinga reports. The brokerage currently has a &#34;hold&#34; rating on the business services provider's stock. Truist Financial's price objective points to a potential upside of 0.88% from the stock's previous close.</p>
<div class="lb-trans"><p>Cross Country Healthcare（纳斯达克：CCRN - 获取免费报告）在周一发布的报告中，Truist Financial 将其目标股价从 10.00 美元上调至 13.25 美元，Benzinga 报道。该券商目前对该商业服务提供商的股票维持 “持有” 评级。Truist Financial 的目标股价表明，相较于股票的前收盘价，存在 0.88% 的潜在上涨空间。</p>
</div><ul>
<li>Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts</li>
</ul>
<div class="lb-trans"><ul>
<li>在降息前值得购买的前两只小型医疗股</li>
</ul>
</div><p>A number of other equities research analysts have also weighed in on CCRN. Weiss Ratings reissued a &#34;sell (e+)&#34; rating on shares of Cross Country Healthcare in a research note on Friday, March 27th. Citigroup lowered Cross Country Healthcare from a &#34;market outperform&#34; rating to a &#34;market perform&#34; rating in a research note on Thursday. Zacks Research raised Cross Country Healthcare from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Monday, January 19th. Wedbush lowered Cross Country Healthcare from an &#34;outperform&#34; rating to a &#34;hold&#34; rating and lowered their price target for the company from $15.00 to $13.25 in a research report on Thursday. Finally, Citizens Jmp lowered Cross Country Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday. Nine analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Cross Country Healthcare presently has an average rating of &#34;Reduce&#34; and a consensus price target of $12.72.</p>
<div class="lb-trans"><p>其他一些股票研究分析师也对 CCRN 发表了看法。Weiss Ratings 在 3 月 27 日的研究报告中重新发布了 Cross Country Healthcare 的 “卖出（e+）” 评级。花旗集团在周四的研究报告中将 Cross Country Healthcare 的评级从 “市场跑赢” 下调至 “市场表现”。Zacks Research 在 1 月 19 日的研究报告中将 Cross Country Healthcare 的评级从 “强烈卖出” 上调至 “持有”。Wedbush 在周四的研究报告中将 Cross Country Healthcare 的评级从 “跑赢大盘” 下调至 “持有”，并将该公司的目标股价从 15.00 美元下调至 13.25 美元。最后，Citizens Jmp 在周四的研究报告中将 Cross Country Healthcare 的评级从 “强烈买入” 下调至 “持有”。九位分析师对该股票给予了 “持有” 评级，一位分析师给予了 “卖出” 评级。根据 MarketBeat.com 的数据，Cross Country Healthcare 目前的平均评级为 “减持”，共识目标股价为 12.72 美元。</p>
</div><p><strong>Read Our Latest Research Report on CCRN</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 CCRN 的最新研究报告</strong></p>
</div><h2>Cross Country Healthcare Stock Down 0.3%</h2>
<div class="lb-trans"><h2>Cross Country Healthcare 股票下跌 0.3%</h2>
</div><ul>
<li>This Small-Cap Healthcare Name Is Outperforming Its Index</li>
</ul>
<div class="lb-trans"><ul>
<li>这只小型医疗股表现优于其指数</li>
</ul>
</div><p>Shares of NASDAQ CCRN traded down $0.05 during midday trading on Monday, reaching $13.14. The company had a trading volume of 181,468 shares, compared to its average volume of 569,250. Cross Country Healthcare has a one year low of $7.43 and a one year high of $14.99. The firm's fifty day moving average price is $9.69 and its 200-day moving average price is $9.66. The stock has a market cap of $422.95 million, a PE ratio of -4.31, a price-to-earnings-growth ratio of 13.87 and a beta of 0.35.</p>
<div class="lb-trans"><p>周一中午交易时，纳斯达克 CCRN 的股票下跌 0.05 美元，报 13.14 美元。该公司的交易量为 181,468 股，而其平均交易量为 569,250 股。Cross Country Healthcare 的年内最低价为 7.43 美元，年内最高价为 14.99 美元。该公司的 50 日移动平均价格为 9.69 美元，200 日移动平均价格为 9.66 美元。该股票的市值为 4.2295 亿美元，市盈率为-4.31，市盈增长比率为 13.87，贝塔值为 0.35。</p>
</div><p>Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last released its earnings results on Thursday, May 7th. The business services provider reported ($0.03) earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.02. Cross Country Healthcare had a negative return on equity of 0.74% and a negative net margin of 9.84%.The company had revenue of $241.06 million during the quarter, compared to analyst estimates of $237.07 million. As a group, equities research analysts expect that Cross Country Healthcare will post 0.09 EPS for the current year.</p>
<div class="lb-trans"><p>Cross Country Healthcare（纳斯达克：CCRN - 获取免费报告）最后一次发布财报是在 5 月 7 日，作为商业服务提供商，该公司报告季度每股收益为（0.03 美元），超出分析师共识预期的（0.05 美元）0.02 美元。Cross Country Healthcare 的股本回报率为-0.74%，净利润率为-9.84%。该公司在本季度的收入为 2.4106 亿美元，而分析师预期为 2.3707 亿美元。整体来看，股票研究分析师预计 Cross Country Healthcare 在当前年度将发布 0.09 美元的每股收益。</p>
</div><h2>Institutional Trading of Cross Country Healthcare</h2>
<div class="lb-trans"><h2>Cross Country Healthcare 的机构交易</h2>
</div><p>Hedge funds and other institutional investors have recently made changes to their positions in the stock. BNP Paribas Financial Markets grew its stake in shares of Cross Country Healthcare by 50.0% in the 2nd quarter. BNP Paribas Financial Markets now owns 3,424 shares of the business services provider's stock worth $45,000 after buying an additional 1,142 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Cross Country Healthcare in the 4th quarter worth approximately $46,000. Tower Research Capital LLC TRC grew its stake in shares of Cross Country Healthcare by 422.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,586 shares of the business services provider's stock worth $47,000 after buying an additional 2,899 shares during the last quarter. Graham Capital Management L.P. purchased a new stake in shares of Cross Country Healthcare in the 4th quarter worth approximately $83,000. Finally, AXQ Capital LP purchased a new stake in shares of Cross Country Healthcare in the 4th quarter worth approximately $109,000. Hedge funds and other institutional investors own 96.03% of the company's stock.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近对该股票的持仓进行了调整。BNP Paribas Financial Markets 在第二季度将其在 Cross Country Healthcare 的股份增加了 50.0%。BNP Paribas Financial Markets 目前拥有 3424 股该商业服务提供商的股票，价值 45,000 美元，此前在上个季度又购买了 1142 股。凯通国际资产管理有限公司在第四季度购买了 Cross Country Healthcare 的新股份，价值约 46,000 美元。Tower Research Capital LLC TRC 在第二季度将其在 Cross Country Healthcare 的股份增加了 422.0%。Tower Research Capital LLC TRC 目前拥有 3586 股该商业服务提供商的股票，价值 47,000 美元，此前在上个季度又购买了 2899 股。Graham Capital Management L.P.在第四季度购买了 Cross Country Healthcare 的新股份，价值约 83,000 美元。最后，AXQ Capital LP 在第四季度购买了 Cross Country Healthcare 的新股份，价值约 109,000 美元。对冲基金和其他机构投资者持有该公司 96.03% 的股票。</p>
</div><h2>About Cross Country Healthcare</h2>
<div class="lb-trans"><h2>关于 Cross Country Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.</p>
<div class="lb-trans"><p>Cross Country Healthcare, Inc.总部位于佛罗里达州博卡拉顿，是美国领先的医疗劳动力解决方案提供商。该公司专注于护理和相关健康专业人员的招聘、安置和管理，提供旅行和永久性岗位。通过其综合平台，Cross Country Healthcare 为医院、健康系统和长期护理设施提供服务，将合格的临床人才与不同护理环境中的患者护理需求相匹配。</p>
</div><p>The company's core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.</p>
<div class="lb-trans"><p>该公司的核心服务包括旅行护士和相关健康人员的招聘、临时人员招聘、永久安置服务和管理服务项目。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Cross Country Healthcare</li>
<li>Meta Platforms’ Wild Post-Earnings Swings: Where Analyst Price Targets Stand Now</li>
<li>3 Metals and Mining Stocks Riding the Commodity Supercycle</li>
<li>Catching Falling Knives: Is Time to Buy These Beaten-Down Stocks?</li>
<li>The Stars Are Aligning For Apple: Get Ready for $300</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Cross Country Healthcare</li>
<li>Meta Platforms 的财报后剧烈波动：分析师目标股价现状</li>
<li>3 只在商品超级周期中表现突出的金属和矿业股票</li>
<li>捕捉下跌的刀子：现在是购买这些被打压股票的时候吗？</li>
<li>星星正在为苹果对齐：准备迎接 300 美元</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0NSTg" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=CCRN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cross Country Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Cross Country Healthcare 吗？</h2>
</div><p>Before you consider Cross Country Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cross Country Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Cross Country Healthcare 并不在名单上。</p>
</div><p>While Cross Country Healthcare currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Cross Country Healthcare 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Cross Country Healthcare (NASDAQ:CCRN) Price Target Raised to $13.25 at Truist Financial

Market Beat

Truist Financial

花旗

Citizens Financial

法国巴黎银行(ADR)

CITIGROUP INC 6.250 NON CUM SER II PFD WI

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SR I

CITIZENS FINANCIAL GROUP INC 5% DEP SHS EA REP 1/40TH NON CUM SER E

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SER H

Cross Country 医疗保健（纳斯达克代码：CCRN）的目标价在 Truist Financial 被上调至 13.25 美元